• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (12)
    • Sullivan, Scott
    • A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease.
    • Arsenicals
    • Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition.
    • C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.
    • See All 12 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.

C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis. Mucosal Immunol. 2018 09; 11(5):1375-1385.

View in: PubMed

subject areas
  • Animals
  • Aspergillus fumigatus
  • Cell Line
  • Chronic Disease
  • Complement C3
  • Disease Models, Animal
  • Epithelial Cells
  • Humans
  • Inflammation
  • Mice
  • Mice, Inbred BALB C
  • Nasal Mucosa
  • Nasal Polyps
  • Proteome
  • Receptors, Complement
  • Rhinosporidiosis
  • Signal Transduction

authors with profiles
  • Jennifer L Mulligan
  • Rodney J. Schlosser
  • Carl Atkinson
  • Stephen Tomlinson
  • Sarah Elizabeth Stephenson
  • Richard R. Drake